Financhill
Sell
37

BZ Quote, Financials, Valuation and Earnings

Last price:
$13.62
Seasonality move :
-4.1%
Day range:
$13.47 - $13.81
52-week range:
$10.57 - $22.74
Dividend yield:
0%
P/E ratio:
30.06x
P/S ratio:
6.23x
P/B ratio:
2.82x
Volume:
5.7M
Avg. volume:
5M
1-year change:
-14.38%
Market cap:
$5.9B
Revenue:
$841.4M
EPS (TTM):
$0.45
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $144.6M $281.7M $659.7M $671.6M $841.4M
Revenue Growth (YoY) -- 94.86% 134.13% 1.81% 25.29%
 
Cost of Revenues $20M $34.8M $85.9M $112.4M $149.8M
Gross Profit $124.6M $246.9M $573.7M $559.2M $691.6M
Gross Profit Margin 86.2% 87.65% 86.98% 83.27% 82.19%
 
R&D Expenses $47.1M $74.4M $127.3M $176.1M $218.2M
Selling, General & Admin $152M $310.8M $609.3M $405M $396.3M
Other Inc / (Exp) $1.4M -$12.8K -$1.5M $3M $4.8M
Operating Expenses $198.7M $383.9M $734.3M $578.5M $609.5M
Operating Income -$74.1M -$136.9M -$160.5M -$19.3M $82.1M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$72.7M -$136.5M -$156.7M $17.4M $172.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- $9.2M $1.5M $17.3M
Net Income to Company -$72.7M -$136.5M -$165.9M $16M $155.4M
 
Minority Interest in Earnings -- -- -- -- $1.3K
Net Income to Common Excl Extra Items -$72.7M -$136.5M -$165.9M $16M $155.4M
 
Basic EPS (Cont. Ops) -$0.24 -$0.41 -$0.72 $0.04 $0.36
Diluted EPS (Cont. Ops) -$0.24 -$0.41 -$0.72 $0.04 $0.34
Weighted Average Basic Share $435.2M $435.2M $264.7M $434.5M $435.2M
Weighted Average Diluted Share $458.5M $458.5M $264.7M $456.1M $451.4M
 
EBITDA -$65.8M -$121.3M -$131.2M $23.5M $142.6M
EBIT -$74.1M -$136.9M -$160.5M -$19.3M $82.1M
 
Revenue (Reported) $144.6M $281.7M $659.7M $671.6M $841.4M
Operating Income (Reported) -$74.1M -$136.9M -$160.5M -$19.3M $82.1M
Operating Income (Adjusted) -$74.1M -$136.9M -$160.5M -$19.3M $82.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $85.2M $187.1M $172M $222M $267M
Revenue Growth (YoY) -- 119.54% -8.05% 29.05% 20.25%
 
Cost of Revenues $9.9M $23.9M $29.3M $37M $43.9M
Gross Profit $75.3M $163.2M $142.7M $185.1M $223.1M
Gross Profit Margin 88.33% 87.22% 82.96% 83.35% 83.57%
 
R&D Expenses $20.2M $32.3M $42.4M $57.3M $64.8M
Selling, General & Admin $50.6M $83.3M $80.7M $93.5M $112.9M
Other Inc / (Exp) -$160.5K $364.3K $7M $4.4M $5.2M
Operating Expenses $70.3M $115.2M $122.6M $149M $177M
Operating Income $5M $48M $20.1M $36.1M $46.1M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $4.9M $48.8M $35M $63.2M $73.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $4.6M $4.1M $4.4M $8.7M
Net Income to Company -- $246.1M -- -- --
 
Minority Interest in Earnings -- -- -- -- $634.8K
Net Income to Common Excl Extra Items $4.9M $44.2M $30.9M $58.8M $65.4M
 
Basic EPS (Cont. Ops) -$0.01 $0.10 $0.07 $0.14 $0.15
Diluted EPS (Cont. Ops) -$0.01 $0.10 $0.07 $0.13 $0.15
Weighted Average Basic Share $436.2M $430.7M $436.2M $435.2M $441.9M
Weighted Average Diluted Share $457.9M $463.7M $457.9M $449.9M $453.4M
 
EBITDA $5M $48M $20.1M $36.1M $46.1M
EBIT $5M $48M $20.1M $36.1M $46.1M
 
Revenue (Reported) $85.2M $187.1M $172M $222M $267M
Operating Income (Reported) $5M $48M $20.1M $36.1M $46.1M
Operating Income (Adjusted) $5M $48M $20.1M $36.1M $46.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- $586.7M $689.8M $773.1M $991.1M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- $74.5M $107M $140.1M $167.3M
Gross Profit -- $512.3M $582.8M $633M $823.8M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- $119.2M $165.7M $199.5M $251.6M
Selling, General & Admin -- $674.7M $349.1M $436.4M $435.3M
Other Inc / (Exp) $73.1K $1.3M $3.7M $2M $4.4M
Operating Expenses -- $791.9M $512M $631.1M $682.5M
Operating Income -- -$279.7M $70.7M $1.9M $141.3M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -$277M $90.3M $87.7M $233.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $4.6M $10.9M $5.9M $31.2M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- $1.7M
Net Income to Common Excl Extra Items -- -$281.7M $79.4M $81.8M $204.3M
 
Basic EPS (Cont. Ops) -- -$3.13 $0.18 $0.19 $0.46
Diluted EPS (Cont. Ops) -- -$3.13 $0.17 $0.18 $0.45
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -$279.7M $70.7M $1.9M $141.3M
EBIT -- -$279.7M $70.7M $1.9M $141.3M
 
Revenue (Reported) -- $586.7M $689.8M $773.1M $991.1M
Operating Income (Reported) -- -$279.7M $70.7M $1.9M $141.3M
Operating Income (Adjusted) -- -$279.7M $70.7M $1.9M $141.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $185.9M $489.4M $519.3M $620.9M $771.6M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $23M $62.5M $83.6M $111.7M $129.2M
Gross Profit $162.8M $426.9M $435.7M $509.3M $642.4M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $51.7M $96.2M $134.7M $158.1M $191.9M
Selling, General & Admin $171.1M $531.9M $272.1M $305.7M $343.8M
Other Inc / (Exp) $73.1K $1.4M $6.5M $5.5M $5.1M
Operating Expenses $221.7M $626.5M $404.6M $459.5M $532M
Operating Income -$58.9M -$199.6M $31.2M $49.7M $110.5M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$58.7M -$197.2M $49.2M $118.2M $180.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $4.6M $6.3M $10.4M $24.4M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- $1.7M
Net Income to Common Excl Extra Items -$58.7M -$201.8M $43M $107.8M $158.3M
 
Basic EPS (Cont. Ops) -$0.22 -$2.91 $0.10 $0.25 $0.36
Diluted EPS (Cont. Ops) -$0.22 -$2.92 $0.09 $0.24 $0.35
Weighted Average Basic Share $1.2B $909.7M $1.3B $1.3B $1.3B
Weighted Average Diluted Share $1.3B $942.7M $1.3B $1.4B $1.4B
 
EBITDA -$55.8M -$199.6M $31.2M $49.7M $110.5M
EBIT -$58.9M -$199.6M $31.2M $49.7M $110.5M
 
Revenue (Reported) $185.9M $489.4M $519.3M $620.9M $771.6M
Operating Income (Reported) -$58.9M -$199.6M $31.2M $49.7M $110.5M
Operating Income (Adjusted) -$58.9M -$199.6M $31.2M $49.7M $110.5M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $58.2M $612M $1.8B $1.4B $348.9M
Short Term Investments $163.2M $82.1M $138.8M $501.2M $1.5B
Accounts Receivable, Net $257K $1.1M $157.2K $1.4M $2.4M
Inventory -- -- -- -- --
Prepaid Expenses $11.8M $13M $47.2M $47.1M $29.1M
Other Current Assets $31.6K $858.5K $3.1M $6.1M $5.1M
Total Current Assets $244.1M $726.6M $2B $2B $1.9B
 
Property Plant And Equipment $24.4M $51.3M $106.4M $142.1M $292.9M
Long-Term Investments -- -- -- -- $348.9M
Goodwill -- -- -- $824.7K $802.7K
Other Intangibles $91.5K $84K $71.9K $1.5M $1.1M
Other Long-Term Assets -- -- $627.5K $579.8K $564.3K
Total Assets $268.6M $778.1M $2.1B $2.1B $2.5B
 
Accounts Payable $6.1M $3M $5.2M $26.9M $88.8M
Accrued Expenses $546.1K -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $8.2M $9.1M $20M $21.9M $21.9M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $144M $263.3M $436.8M $439.3M $614.7M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $505.9M $1.1B $465.6M $461.8M $636.4M
 
Common Stock $8.9K $12.4K $86.9K $81.8K $79.6K
Other Common Equity Adj $2.7M -$20M -$40.4M $100.8M $127.5M
Common Equity -$237.4M -$352.1M $1.7B $1.7B $1.9B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- -$1.3K
Total Equity -$237.4M -$352.1M $1.7B $1.7B $1.9B
 
Total Liabilities and Equity $268.6M $778.1M $2.1B $2.1B $2.5B
Cash and Short Terms $221.4M $694.1M $1.9B $1.9B $1.8B
Total Debt -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- $1.7B $1.6B $335.1M $401.6M
Short Term Investments -- $183.1M $387.9M $1.4B $1.7B
Accounts Receivable, Net -- $114.2K $633K $2.3M $4.2M
Inventory -- -- -- -- $408.6K
Prepaid Expenses -- $93.1M $77.1M -- --
Other Current Assets -- -- -- $87.1M $72.2M
Total Current Assets -- $1.9B $2B $1.8B $2.2B
 
Property Plant And Equipment -- $81.9M $120.9M $197.7M $308.4M
Long-Term Investments -- -- -- $329.7M $176.2M
Goodwill -- -- -- $779.9K $930.9K
Other Intangibles -- $74.3K $54.7K $1.2M $37.3M
Other Long-Term Assets -- $618.1K $561.3K $548.2K --
Total Assets -- $2B $2.2B $2.4B $2.7B
 
Accounts Payable -- $5.1M $7.3M $46.7M $11.6M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- $15.5M $21.1M $18.7M $27.4M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- $379.1M $404.1M $502.1M $569M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- $403.5M $427.1M $520.6M $596M
 
Common Stock -- $84.8K $78.6K -- --
Other Common Equity Adj -- -$12.7M $125.7M -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- $1.6B $1.7B $1.9B $2.1B
 
Total Liabilities and Equity -- $2B $2.2B $2.4B $2.7B
Cash and Short Terms -- $1.8B $2B $1.8B $2.1B
Total Debt -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$72.7M -$136.5M -$165.9M $16M $155.4M
Depreciation & Amoritzation $8.3M $15.7M $29.3M $42.8M $60.5M
Stock-Based Compensation $5M $18M $64.6M $103.1M $149.4M
Change in Accounts Receivable -$4.3M -$1.2M $1.5M -$756.4K -$747.7K
Change in Inventories -- -- -- -- --
Cash From Operations -$15.3M $57.4M $254.2M $149.3M $430.8M
 
Capital Expenditures $9.3M $20M $40.3M $50.6M $135.1M
Cash Acquisitions -- -- -- -$1.5M -$9.3K
Cash From Investing -$177.2M $67.7M -$93.2M -$419.3M -$1.4B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- -$79.6M
Special Dividend Paid
Long-Term Debt Issued $4.3M -- -- -- --
Long-Term Debt Repaid -$4.3M -- -- -- --
Repurchase of Common Stock -- -- -$1.8M -$136.8M -$10.2M
Other Financing Activities -- -- -- -- --
Cash From Financing $143.8M $417.6M $996.1M -$99.6M -$59M
 
Beginning Cash (CF) $101.4M $59M $619.2M $1.7B $1.4B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$48.6M $542.7M $1.2B -$369.6M -$1B
Ending Cash (CF) $59M $579.4M $1.8B $1.5B $349.6M
 
Levered Free Cash Flow -$24.6M $37.3M $214M $98.7M $295.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- $246.1M -- -- --
Depreciation & Amoritzation -- -$12.2M -- -- --
Stock-Based Compensation -- -$31.4M -- -- --
Change in Accounts Receivable -- -$842.1K -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $33.2M $41.4M $51M $106.4M $114.6M
 
Capital Expenditures -- -$12.6M -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$34M -$98.5M -$290.4M -$108.6M -$97.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- $1.8M -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $15M -$2.7M $7.3M -$6.4M -$105.4M
 
Beginning Cash (CF) $317M $1.7B $1.8B $391.1M $482.8M
Foreign Exchange Rate Adjustment -$11.9M $5.9M $79.6M -$854.7K -$2.3M
Additions / Reductions $14.2M -$59.8M -$232.2M -$8.6M -$88.7M
Ending Cash (CF) $320.8M $1.7B $1.6B $337.8M $393.3M
 
Levered Free Cash Flow $33.2M $54M $51M $106.4M $114.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- $18M $64.6M -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- $236.4M $207.1M $318.6M $499M
 
Capital Expenditures -- $20M $40.3M -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -$171.9M -$274.1M -$1.4B -$280M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- $1.2B $286.3K -$90.1M -$193.7M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- $1.3B -$66.7M -$1.2B $25.3M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- $216.3M $207.1M $318.6M $499M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$8.2M $170.9M $123.7M $293M $361.2M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing $115.2M -$124.4M -$305.3M -$1.3B -$180.7M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $162.9M $989.8M -$6M $3.5M -$131.3M
 
Beginning Cash (CF) $701.4M $3B $5.4B $2.7B $1.2B
Foreign Exchange Rate Adjustment -$8M $7.3M $160.9M -$463.8K -$1.3M
Additions / Reductions $269.9M $1B -$187.6M -$1B $49.2M
Ending Cash (CF) $963.8M $4B $5.3B $1.6B $1.3B
 
Levered Free Cash Flow -$8.2M $170.9M $123.7M $293M $361.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 9.73% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 13.45% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 2.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock